COVID-19 and Inflammatory Bowel Diseases: Risk Assessment, Shared Molecular Pathways, and Therapeutic Challenges

BACKGROUND: The novel coronavirus SARS-CoV-2 causing COVID-19 disease is yielding a global outbreak with severe threats to public health. In this paper, we aimed at reviewing the current knowledge about COVID-19 infectious risk status in inflammatory bowel disease (IBD) patients requiring immunosupp...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Gastroenterol Res Pract
Main Authors: Popa, Iolanda Valentina, Diculescu, Mircea, Mihai, Cătălina, Cijevschi-Prelipcean, Cristina, Burlacu, Alexandru
Format: Artigo
Jezik:Inglês
Izdano: Hindawi 2020
Teme:
Review Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7352130/
https://ncbi.nlm.nih.gov/pubmed/32714386
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/1918035
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki